APYX vs CME · rev $48.1M vs P/E 22, rev $6.52B
Apyx Medical Inc (APYX) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
APYX currently screens at market cap $179.6M. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the APYX and CME stock pages for the full models.
Not investment advice.